SQZ Biotechnologies (SQZ) Short Interest Ratio & Short Volume → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free SQZ Stock Alerts $0.05 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media SQZ Biotechnologies Short Interest DataCurrent Short Volume811,200 sharesPrevious Short Volume762,700 sharesChange Vs. Previous Month+6.36%Dollar Volume Sold Short$438,048.00Short Interest Ratio / Days to Cover3.1Last Record DateJune 15, 2023Outstanding Shares29,491,000 sharesFloat Size21,510,000 sharesShort Percent of Float3.77%Today's Trading Volume0 sharesAverage Trading Volume455,220 sharesToday's Volume Vs. Average0% Short Selling SQZ Biotechnologies ? Sign up to receive the latest short interest report for SQZ Biotechnologies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSQZ Short Interest Over TimeSQZ Days to Cover Over TimeSQZ Percentage of Float Shorted Over Time Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. SQZ Biotechnologies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/2023811,200 shares $438,048.00 +6.4%3.8%3.1 $0.54 5/31/2023762,700 shares $423,298.50 +2.7%3.6%2.6 $0.56 5/15/2023743,000 shares $475,520.00 -10.2%3.5%2.5 $0.64 4/30/2023827,500 shares $529,600.00 +1.9%3.9%2.7 $0.64 4/15/2023812,400 shares $552,432.00 +7.6%3.8%2.4 $0.68 3/31/2023755,000 shares $422,800.00 +164.3%3.5%2.2 $0.56 Get the Latest News and Ratings for SQZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SQZ Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. 3/15/2023285,700 shares $151,421.00 +12.1%1.2%0.8 $0.53 2/28/2023254,900 shares $187,122.09 -5.2%1.1%1.9 $0.73 2/15/2023268,900 shares $220,471.11 +1.9%1.1%2 $0.82 1/31/2023264,000 shares $216,480.00 -11.2%1.2%2.1 $0.82 1/15/2023297,200 shares $255,592.00 +2.5%1.4%3 $0.86 12/30/2022290,100 shares $214,674.00 -9.9%1.3%3.3 $0.74 12/15/2022322,100 shares $297,684.82 +2.9%1.5%4.3 $0.92 11/30/2022313,100 shares $785,881.00 -4.4%1.4%5.6 $2.51 11/15/2022327,500 shares $903,900.00 +5.7%1.5%8.4 $2.76 10/31/2022309,900 shares $883,215.00 -34.8%1.4%6.1 $2.85 10/15/2022475,100 shares $1.37 million -31.0%2.2%8.2 $2.89 9/30/2022688,500 shares $1.57 million -1.8%3.2%13.2 $2.28 9/15/2022701,400 shares $2.04 million +0.1%3.3%6.9 $2.91 8/31/2022700,700 shares $2.10 million +0.2%3.3%6.2 $3.00 8/15/2022699,200 shares $2.38 million -11.7%3.3%4.9 $3.40 7/31/2022791,900 shares $2.21 million -4.7%3.9%5 $2.79 7/15/2022830,600 shares $2.73 million -12.0%4.1%1.6 $3.29 6/30/2022944,100 shares $3.00 million -40.6%4.6%1.7 $3.18 6/15/20221,590,000 shares $5.14 million -1.2%7.8%2.9 $3.23 5/31/20221,610,000 shares $5.72 million -15.7%7.9%3.3 $3.55 5/15/20221,910,000 shares $6.34 million +2.1%10.1%4 $3.32 4/30/20221,870,000 shares $6.90 million +22.2%10.7%4.1 $3.69 4/15/20221,530,000 shares $6.52 million +2.7%8.7%16.5 $4.26 3/31/20221,490,000 shares $7.17 million -6.3%8.5%18.9 $4.81 3/15/20221,590,000 shares $6.60 million +3.3%9.1%19.6 $4.15 2/28/20221,540,000 shares $8.12 million +15.8%8.8%17.9 $5.27 2/15/20221,330,000 shares $8.84 million +23.2%6.9%15.1 $6.65 1/31/20221,080,000 shares $8.66 million +0.9%6.2%13.4 $8.02 1/15/20221,070,000 shares $8.72 million +2.9%5.7%14.6 $8.15 12/31/20211,040,000 shares $9.29 million +20.5%5.5%14.8 $8.93 12/15/2021863,100 shares $8.38 million -4.6%4.6%13.1 $9.71 11/30/2021904,300 shares $11.90 million -3.0%4.8%14.8 $13.16 11/15/2021932,500 shares $13.25 million -11.2%4.9%15.1 $14.21 10/29/20211,050,000 shares $14.06 million No Change5.5%16.7 $13.39Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. SQZ Short Interest - Frequently Asked Questions What is SQZ Biotechnologies' current short interest? Short interest is the volume of SQZ Biotechnologies shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 811,200 shares of SQZ short. 3.77% of SQZ Biotechnologies' shares are currently sold short. Learn More on SQZ Biotechnologies' current short interest. What is a good short interest ratio for SQZ Biotechnologies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SQZ shares currently have a short interest ratio of 3.0. Learn More on SQZ Biotechnologies's short interest ratio. What is a good short interest percentage for SQZ Biotechnologies? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.77% of SQZ Biotechnologies' floating shares are currently sold short. Is SQZ Biotechnologies' short interest increasing or decreasing? SQZ Biotechnologies saw a increase in short interest in June. As of June 15th, there was short interest totaling 811,200 shares, an increase of 6.4% from the previous total of 762,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is SQZ Biotechnologies' float size? SQZ Biotechnologies currently has issued a total of 29,491,000 shares. Some of SQZ Biotechnologies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. SQZ Biotechnologies currently has a public float of 21,510,000 shares. How does SQZ Biotechnologies' short interest compare to its competitors? 3.77% of SQZ Biotechnologies' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to SQZ Biotechnologies: TC Biopharm (Holdings) Plc (34.94%), Scinai Immunotherapeutics Ltd. (1.20%), Acorda Therapeutics, Inc. (0.66%), Gamida Cell Ltd. (7.11%), Avalon GloboCare Corp. (2.84%), TRACON Pharmaceuticals, Inc. (1.16%), Finch Therapeutics Group, Inc. (1.96%), Palisade Bio, Inc. (4.12%), Fresh Tracks Therapeutics, Inc. (0.17%), GRI Bio, Inc. (0.61%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.80 billion), Canadian Natural Resources Limited ($3.69 billion), Charter Communications, Inc. ($2.95 billion), Occidental Petroleum Co. ($2.78 billion), Moderna, Inc. ($2.38 billion), Palantir Technologies Inc. ($2.29 billion), T. Rowe Price Group, Inc. ($2.19 billion), Coinbase Global, Inc. ($2.08 billion), Royal Caribbean Cruises Ltd. ($2.02 billion), and Verisk Analytics, Inc. ($1.96 billion). View all of the most shorted stocks. What does it mean to sell short SQZ Biotechnologies stock? Short selling SQZ is an investing strategy that aims to generate trading profit from SQZ Biotechnologies as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against SQZ Biotechnologies? A short squeeze for SQZ Biotechnologies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SQZ, which in turn drives the price of the stock up even further. How often is SQZ Biotechnologies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SQZ, twice per month. The most recent reporting period available is June, 15 2023. More Short Interest Resources from MarketBeat Related Companies: TC Biopharm Short Squeeze Scinai Immunotherapeutics Short Squeeze Acorda Therapeutics Short Squeeze Gamida Cell Short Squeeze Avalon GloboCare Short Squeeze TRACON Pharmaceuticals Short Squeeze Finch Therapeutics Group Short Squeeze Palisade Bio Short Squeeze Fresh Tracks Therapeutics Short Squeeze GRI Bio Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:SQZ) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals